MSG
EW icon

Main Street Group’s Edwards Lifesciences EW Stock Holding History

Main Street Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.1K Hold
200
– – ﹤0.01% 468
2026
Q1 		$16K Buy
+200
New +$16.5K ﹤0.01% 470
2025
Q4 		– Sell
-200
Closed -$15.6K – 248
2025
Q3 		$15.6K Hold
200
– – ﹤0.01% 450
2025
Q2 		$15.6K Hold
200
– – 0.01% 427
2025
Q1 		$14.5K Hold
200
– – 0.01% 459
2024
Q4 		$14.8K Hold
200
– – 0.01% 444
2024
Q3 		$13.2K Sell
200
-8
-4% -$581 0.01% 456
2024
Q2 		$18.8K Hold
208
– – 0.01% 422
2024
Q1 		$19.6K Hold
208
– – 0.01% 436
2023
Q4 		$15.9K Buy
+208
New +$14.5K 0.01% 687

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Main Street Group's EW Position: Q2 2026 in Review

Main Street Group held its Edwards Lifesciences (EW) position steady in Q2 2026 at 200 shares worth $18.1K. The position accounts for ﹤0.01% of the portfolio, ranked #468.

Main Street Group first reported a position in EW in Q4 2023 and has held it in 10 quarters since. The position peaked at $19.6K in Q1 2024. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Main Street Group held 200 shares of Edwards Lifesciences worth $18.1K as of Q2 2026.
  • Main Street Group left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of Main Street Group's portfolio in Q2 2026, its #468 holding.
  • Main Street Group first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 10 quarters since.
  • Main Street Group's Edwards Lifesciences position peaked at $19.6K in Q1 2024.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.